Bias, Corruption & Accountability

Data shows that over a third of users experience permanent memory loss and that approximately half report not receiving adequate information about the risks from their doctors.

Between 2,150 and 4,100 children suffered from severe malformations connected to valproate prescription.

Previously taking antidepressants could make individuals less likely to respond to treatment for bipolar II depression.

Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

Study finds more patients are visiting physicians who have ties to industry than previously thought.

The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.

Behind the U.S. task force recommendation to screen all children and adults for depression.

Findings point to association between race and the mental health care experiences of African-American and White veterans.

A meta-analysis looks at the effects of researcher background on study findings for trials comparing pharmacotherapy and psychotherapy for depression.

Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed

Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD

Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.

New research investigates the financial conflicts of interest (FCOI) of patient advocacy organizations (PAOs) in the United States.

A new study analyzing over 21,000 participants found that differences in activation of brain regions in different psychological “disorders” may have been overestimated, and confirms that there is still no brain scan capable of diagnosing a mental health concern.

BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics

New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms

The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.

The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.

Researchers find no benefits for testosterone as a treatment for improving mood, psychological well-being, and cognitive function.

Researchers discuss the preliminary results of clinical trial data sharing efforts by pharmaceutical companies and other groups.

Neuroscientific results that class humans into two categories, “male” and “female,” tend to reify gender stereotypes by giving them the appearance of objective scientific truth.

When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.

A new study examines the wide range of symptoms that appear on depression rating scales and what the means for the reliability of research.

A recent review found that hypnotic medications are associated with risks of suicide and suicidal ideation.